{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:59:54Z","timestamp":1764691194217,"version":"3.46.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.7759\/cureus.98318","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:56:37Z","timestamp":1764690997000},"source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal Fluid Autoantibody Profiles in Rheumatologic Disorders Affecting the Central Nervous System: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Taher","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Venkatachalapathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiranjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashal","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahvish","family":"Nishat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ensaf Ibrahim Hassan","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/910352","article-title":"A systematic review of peripheral and central nervous system involvement of rheumatoid arthritis, systemic lupus erythematosus, primary Sj\u00f6gren's syndrome, and associated immunological profiles","volume":"2015","author":"Bougea A","year":"2015","unstructured":"Bougea A, Anagnostou E, Konstantinos G, George P, Triantafyllou N, Kararizou E. A systematic review of peripheral and central nervous system involvement of rheumatoid arthritis, systemic lupus erythematosus, primary Sj\u00f6gren's syndrome, and associated immunological profiles. Int J Chronic Dis. 2015, 2015:910352. 10.1155\/2015\/910352","journal-title":"Int J Chronic Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14030242","article-title":"Cerebrospinal fluid analysis in rheumatological diseases with neuropsychiatric complications and manifestations: a narrative review","volume":"14","author":"Castellazzi M","year":"2024","unstructured":"Castellazzi M, Candeloro R, Pugliatti M, Govoni M, Silvagni E, Bortoluzzi A. Cerebrospinal fluid analysis in rheumatological diseases with neuropsychiatric complications and manifestations: a narrative review. Diagnostics (Basel). 2024, 14:10.3390\/diagnostics14030242","journal-title":"Diagnostics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03538-3","article-title":"Concomitant Sj\u00f6gren's disease in patients with NMOSD: impacts on neurologic disease severity and recurrence","volume":"27","author":"Wu W","year":"2025","unstructured":"Wu W, Yang W, Deng B, et al.. Concomitant Sj\u00f6gren's disease in patients with NMOSD: impacts on neurologic disease severity and recurrence. Arthritis Res Ther. 2025, 27:78. 10.1186\/s13075-025-03538-3","journal-title":"Arthritis Res Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ph17081044","article-title":"Central nervous system involvement in systemic autoimmune rheumatic diseases\u2014diagnosis and treatment","volume":"17","author":"Juncker AS","year":"2024","unstructured":"Juncker AS, Appenzeller S, de Souza JM. Central nervous system involvement in systemic autoimmune rheumatic diseases\u2014diagnosis and treatment. Pharmaceuticals (Basel). 2024, 17:10.3390\/ph17081044","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1366531","article-title":"Case report: Overlap syndrome of neuromyelitis optica spectrum disorder with anti-Argonaute antibodies","volume":"15","author":"Liu P","year":"2024","unstructured":"Liu P, Lin X, Wu S. Case report: Overlap syndrome of neuromyelitis optica spectrum disorder with anti-Argonaute antibodies. Front Immunol. 2024, 15:1366531. 10.3389\/fimmu.2024.1366531","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001459","article-title":"Neurologic manifestations of rheumatologic disorders","volume":"30","author":"McCombe JA","year":"2024","unstructured":"McCombe JA. Neurologic manifestations of rheumatologic disorders. Continuum (Minneap Minn). 2024, 30:1189-225. 10.1212\/CON.0000000000001459","journal-title":"Continuum (Minneap Minn)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1524839919893361","article-title":"A review of the PubMed PICO tool: using evidence-based practice in health education","volume":"21","author":"Brown D","year":"2020","unstructured":"Brown D. A review of the PubMed PICO tool: using evidence-based practice in health education. Health Promot Pract. 2020, 21:496-8. 10.1177\/1524839919893361","journal-title":"Health Promot Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang A","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010, 25:603-5. 10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-22-00125","article-title":"Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process","volume":"21","author":"Barker TH","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, et al.. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023, 21:478-93. 10.11124\/JBIES-22-00125","journal-title":"JBI Evid Synth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"3","author":"Fragoso-Loyo H","year":"2008","unstructured":"Fragoso-Loyo H, Cabiedes J, Orozco-Narv\u00e1ez A, et al.. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One. 2008, 3:e3347. 10.1371\/journal.pone.0003347","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.21547","article-title":"Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus","volume":"54","author":"Yoshio T","year":"2006","unstructured":"Yoshio T, Onda K, Nara H, Minota S. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2006, 54:675-8. 10.1002\/art.21547","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/ar2184","article-title":"Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"9","author":"Hirohata S","year":"2007","unstructured":"Hirohata S, Arinuma Y, Takayama M, Yoshio T. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther. 2007, 9:R44. 10.1186\/ar2184","journal-title":"Arthritis Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma Y","year":"2008","unstructured":"Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008, 58:1130-5. 10.1002\/art.23399","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126643","article-title":"Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus","volume":"10","author":"Hu C","year":"2015","unstructured":"Hu C, Huang W, Chen H, et al.. Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus. PLoS One. 2015, 10:e0126643. 10.1371\/journal.pone.0126643","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196487","article-title":"Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with systemic lupus erythematosus and cognitive dysfunction","volume":"13","author":"Duarte-Garc\u00eda A","year":"2018","unstructured":"Duarte-Garc\u00eda A, Romero-D\u00edaz J, Ju\u00e1rez S, et al.. Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with systemic lupus erythematosus and cognitive dysfunction. PLoS One. 2018, 13:e0196487. 10.1371\/journal.pone.0196487","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000098469","article-title":"Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement","volume":"57","author":"M\u00e9gevand P","year":"2007","unstructured":"M\u00e9gevand P, Chizzolini C, Chofflon M, Roux-Lombard P, Lalive PH, Picard F. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement. Eur Neurol. 2007, 57:166-71. 10.1159\/000098469","journal-title":"Eur Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance","volume":"7","author":"Jarius S","year":"2010","unstructured":"Jarius S, Franciotta D, Paul F, et al.. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation. 2010, 7:52. 10.1186\/1742-2094-7-52","journal-title":"J Neuroinflammation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24208","article-title":"Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks","volume":"76","author":"Sato DK","year":"2014","unstructured":"Sato DK, Callegaro D, de Haidar Jorge FM, et al.. Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks. Ann Neurol. 2014, 76:305-9. 10.1002\/ana.24208","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102401","article-title":"Anti-cyclic citrullinated peptide antibody index in the cerebrospinal fluid for the diagnosis and monitoring of rheumatoid meningitis","volume":"10","author":"Caputi L","year":"2022","unstructured":"Caputi L, Boncoraglio GB, Bernardi G, et al.. Anti-cyclic citrullinated peptide antibody index in the cerebrospinal fluid for the diagnosis and monitoring of rheumatoid meningitis. Biomedicines. 2022, 10:10.3390\/biomedicines10102401","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/435881-cerebrospinal-fluid-autoantibody-profiles-in-rheumatologic-disorders-affecting-the-central-nervous-system-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:56:38Z","timestamp":1764690998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/435881-cerebrospinal-fluid-autoantibody-profiles-in-rheumatologic-disorders-affecting-the-central-nervous-system-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.98318","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}